NCT00133822View on ClinicalTrials.gov

Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Post-Traumatic Stress Disorders
Interventions
DRUG

Sertraline and Risperidone

Trial Locations (3)

27710

Duke University Medical Center South, Durham

30322

Emory University School of Medicine, Atlanta

Unknown

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

Janssen, LP

INDUSTRY

lead

Emory University

OTHER

NCT00133822 - Civilian Post-Traumatic Stress Disorder Risperidone Clinical Trial | Biotech Hunter | Biotech Hunter